Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Sernova Corp (SVA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.43 0.01    0.00%
10:49:24 - Delayed Data. Currency in CAD ( Disclaimer )
Type:  Equity
Market:  Canada
  • Volume: 167,507
  • Bid/Ask: 0.43 / 0.44
  • Day's Range: 0.42 - 0.44
Sernova 0.43 0.01 0.00%

Sernova Corp Company Profile

 
Get an in-depth profile of Sernova Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

-

Equity Type

ORD

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

Contact Information

Address The Stiller Centre Suite 114
700 Collip Circle London, N6G 4X8
Canada
Phone 519 858 5126
Fax 519 858 5099

Top Executives

Name Age Since Title
Clive Patience 60 2006 Member of Scientific Advisory Board
Steven Paraskevas - 2010 Member of Scientific Advisory Board
David Lillicrap - 2019 Member of Scientific Advisory Board
Anke M. Schulte - 2020 Member of Global Advisory Board
Sam Wiseman - 2021 Member of Scientific Advisory Board
George L. King - - Member of Scientific Advisory Board
Norman C. W. Wong - 2006 Member of Scientific Advisory Board
Jannette Dufour - 2006 Member of Scientific Advisory Board
James T. Parsons 59 2012 Independent Director
Stephen Sangha - 2023 Independent Director
Brett Alexander Whalen 48 2023 Independent Chairman
Daniel Mahony - 2022 Independent Director
Bertram T. Von Plettenberg - 2023 Independent Director
Philip M. Toleikis - 2009 President, CTO, Director of Technology & Director
Cynthia Pussinen - 2023 CEO & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SVA Comments

Write your thoughts about Sernova Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Cognacthe Maniac
Cognac Sep 28, 2022 8:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Currently able to buy the $.35 cad warrant shares that were all exercised by Sept 22, 2022. Some 19 million. Good time to be accumulating below $.65 us.  This amidst a warrant exercise @$2.50 cad a month ago by a new “partner”. Warrants next spring @ $1.70 may not get exercised…..
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email